We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Healthy Breast Fat Cells May Help Combat Invasive Cancer Progression

Clinical patient samples from a healthy donor after reduction mammoplasty surgery or suffering from invasive ductal carcinoma, younger or older patient groups.
Figure. A, clinical patient samples from a healthy donor after reduction mammoplasty surgery (left), or suffering from invasive ductal carcinoma (right). Scale bar, 200 μm. B, labelling of IGFBP2 (magenta) in adipocytes in younger (left) or older (right) patient groups after normal reduction mammoplasty. Cell nuclei are given in cyan and extracellular matrix, such as collagen, in green. Scale bar, 100 μm. Credit: University of Turku
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Researchers have found a possible explanation as to why higher breast density and older age increase the risk of breast cancer.


In an innovative study, researchers at the Turku Bioscience Centre, InFLAMES Flagship of the University of Turku, and Turku University Hospital, Finland, have made an extraordinary discovery that turns conventional wisdom on its head. Their findings reveal that healthy fat cells in the breast, also known as adipocytes, secrete a potent factor called IGFBP2, which acts as a barrier against invasive breast cancer progression.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

"Adipocytes generally get a bad rap for promoting cancer progression, but this study demonstrates that healthy breast fat can play a protective role in the maintenance of tissue homeostasis and cancer containment," explained Dr. Emilia Peuhu, a key collaborator in the study. “It's time to re-evaluate our assumptions and recognize the important role of these unsung heroes.”


Breast cancer patients who experience the transition from pre-malignant ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) face a considerably poorer prognosis and an increased risk of developing metastatic disease. The research team's work focuses on identifying factors that impede this invasive progression, with IGFBP2 emerging as a key factor secreted by healthy adipocytes.


In addition to the loss of adipocytes that occurs as women age, this study found that older women had reduced expression of IGFBP2, suggesting that the anti-cancer activities of breast adipocytes might also decrease with age.


InFLAMES group leader, Professor Johanna Ivaska, the principle investigator on the project, expressed their astonishment at the findings, highlighting that, "increasing age and higher breast density, with fewer adipocytes, are two well established risk factors for the development of breast cancer. Our research provides a possible explanation for this increased risk, as we found that IGFBP2 levels are also reduced in older individuals and that healthy breast adipocytes can secrete factors, such as IGFBP2, to inhibit tumour progression.”


The implications of this discovery extend to the understanding of mammary density and its connection with poorer prognosis. Dr. James Conway, the lead researcher of the team, added, "While restoring IGFBP2 into the mammary environment might not be possible, the use of antibody-based inhibitors of IGF-II could help to contain non-invasive breast lesions by acting in a similar fashion to IGFBP2 itself, which we have already observed in our model systems.”


The team is now exploring the therapeutic avenues that have opened up as a result of these recent findings.


Reference: Conway JRW, Dinç DD, Follain G, et al. IGFBP2 secretion by mammary adipocytes limits breast cancer invasion. Sci Adv. 2023;9(28):eadg1840. doi: 10.1126/sciadv.adg1840


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.